On 25 February 2025, GSK plc acquired 809,900 shares at prices ranging from 1,455.00p to 1,489.50p under their buyback program, bringing total treasury shares to 170,881,355 and total shares issued to 4,144,285,716. The company's total shares purchased since 24 February 2025 is now 1,811,052.